Quick answers
- What is Quelicin?
- Quelicin is a brand name of Succinylcholine, a prescription medicine. The FDA NDC Directory lists 1 Quelicin product in 1 strength and form.
- Who makes Quelicin?
- Hospira holds the FDA application for Quelicin (NDA008845, approved May 1, 1953).
- Is there a generic or store brand of Quelicin?
- Yes. The FDA NDC Directory lists 28 other products with the same active ingredients, strength and form as a Quelicin product, 25 of them generic. Ask your pharmacist whether one is right for you.
- Has Quelicin been recalled?
- FDA enforcement reports list 3 recalls of Quelicin products; the newest started June 15, 2017. A recall usually concerns specific lots, not every product.
What Quelicin is
Each Quelicin product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Succinylcholine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| succinylcholine chloride 20 mg/mL injection, solution (intramuscular, intravenous) | Quelicin | 28 products, 22 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Succinylcholine →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA008845 | Hospira | May 1, 1953 | 1 |
Companies that list Quelicin
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Quelicin products.
- Hospira, Inc.1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
June 15, 2017 · Class II · Terminated · D-1048-2017
Lack of Sterility Assurance
Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M. use. a.) one vial (NDC: 0409-6629-02), b.) 25 vial carton (NDC: 0409-6629-25). — Hospira a Pfizer Company
-
March 15, 2016 · Class III · Ongoing · D-0836-2016
Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.
Quelicin (Succinylcholine Chloride) Injection, USP 200 mg. (20 mg/mL), 10 mL Multiple-dose vial, packaged in 25 Unit vials per carton, Rx only, HOSPIRA, INC., LAKE FOREST, IL 60045 USA, NDC 0409-6629-02 — Hospira Inc.
-
February 26, 2013 · Class II · Terminated · D-315-2013
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, , NDC 0409-6629-02 — Hospira Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.